EUVIMEDEUVIMED entdecken
Kohortenstudie

Factors associated with disease severity in adults with acute glomerulonephritis: a descriptive retrospective cohort study

Kazunori Sakoda, Kayoko Mizuno, Kanna Shinkawa, Ayano Hayashi, Satomi Yoshida, Toshiya Takeda, Motoko Yanagita iD, Koji Kawakami iD

Journal of Nephrology · 20.08.2026

DOI: 10.1093/joneph/aajag229 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Nephrology, online erschienen am 20.08.2026. Verfasst von Kazunori Sakoda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute glomerulonephritis (AGN) is relatively common and rare in children and adults, respectively. We aimed to describe the clinical characteristics associated with AGN severity in adults using a large-scale database.

Methods

We extracted data regarding patients diagnosed with AGN between January 2001 and December 2023 from a Real World Data database. We performed univariable and multivariable logistic regression analyses to evaluate clinical characteristics associated with disease severity in the acute and chronic phases. Additionally, we performed univariable and multivariable modified Poisson regression analysis as a sensitivity analysis.

Results

Among 6795 patients diagnosed with AGN, we included 1002 eligible patients. Age, maximum occult blood in dipstick, and maximum proteinuria in dipstick were associated with the occurrence of stage 1 or higher acute kidney injury within 30 days of AGN onset (adjusted odds ratios [95% confidence interval (CI)]: 1.04 [1.03–1.05], 1.24 [1.06–1.45], and 1.61 [1.39–1.87], respectively). Age, maximum proteinuria in dipstick, hypertension, and maximum serum creatinine ≥2 mg/dL were associated with progression of chronic kidney disease at 1 year after AGN onset (adjusted odds ratios [95% CI]: 1.02 [1.01–1.04], 1.86 [1.59–2.19], 1.55 [1.08–2.22], and 3.02 [1.79–5.11], respectively). Similar results were obtained in the sensitivity analysis.

Conclusion

Our findings describe clinical characteristics associated with disease severity in adults with AGN. These findings should be interpreted as descriptive associations and may contribute to a better understanding of disease severity during hospitalization and follow-up after discharge.

Schlagwörter

Stichwörter der Autor:innen

Acute glomerulonephritisAcute kidney injuryChronic kidney disease

Autor:innen und Institutionen

  • Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Pharmacoepidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Nephrology, Kyoto Takeda hospital, Kyoto, Japan.
  • Division of Social Medicine, Department of Clinical Medicine, Institute of Medicine, University of Tsukuba.
  • Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.

ORCID-Profile: Motoko Yanagita, Koji Kawakami

Zitieren

APA

Sakoda, K., Mizuno, K., Shinkawa, K., Hayashi, A., Yoshida, S., Takeda, T., Yanagita, M., & Kawakami, K. (2026). Factors associated with disease severity in adults with acute glomerulonephritis: a descriptive retrospective cohort study. Journal of Nephrology. https://doi.org/10.1093/joneph/aajag229

Vancouver

Sakoda K, Mizuno K, Shinkawa K, Hayashi A, Yoshida S, Takeda T, et al. Factors associated with disease severity in adults with acute glomerulonephritis: a descriptive retrospective cohort study. Journal of Nephrology. 2026. doi:10.1093/joneph/aajag229

BibTeX
@article{Sakoda2026,
  author = {Sakoda, Kazunori and Mizuno, Kayoko and Shinkawa, Kanna and Hayashi, Ayano and Yoshida, Satomi and Takeda, Toshiya and Yanagita, Motoko and Kawakami, Koji},
  title = {Factors associated with disease severity in adults with acute glomerulonephritis: a descriptive retrospective cohort study},
  journal = {Journal of Nephrology},
  year = {2026},
  doi = {10.1093/joneph/aajag229}
}
Kostenlos starten →